Brain Receptor Nailed Down as Drug Target for Obesity and Eating Disorders (IMAGE)

American Association for the Advancement of Science (AAAS)

Brain Receptor Nailed Down as Drug Target for Obesity and Eating Disorders

Caption

Researchers have identified a compound that boosts appetite and promotes weight gain in mice by activating a brain receptor that regulates feeding behavior. This material relates to a paper that appeared in the June 1, 2016 issue of Science Signaling, published by AAAS. The paper, by J.H. Wardman at Icahn School of Medicine at Mount Sinai New York, NY, and colleagues was titled, "Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake."

Credit

V. Altounian / <i>Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.